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Abstract
Background Many demographic and physiological vari-
ables have been associated with TBI outcomes. However,
with small sample sizes, making spurious inferences is
possible. This paper explores the effect of sample sizes on
statistical relationships between patient variables (both
physiological and demographic) and outcome.
Methods Data from head-injured patients with monitored
arterial blood pressure, intracranial pressure (ICP) and
outcome assessed at 6 months were included in this ret-
rospective analysis. A univariate logistic regression
analysis was performed to obtain the odds ratio for unfa-
vorable outcome. Three different dichotomizations
between favorable and unfavorable outcomes were con-
sidered. A bootstrap method was implemented to estimate
the minimum sample sizes needed to obtain reliable asso-
ciation between physiological and demographic variables
with outcome.
Results In a univariate analysis with dichotomized out-
come, samples sizes should be generally larger than 100 for
reproducible results. Pressure reactivity index, ICP, and
ICP slow waves offered the strongest relationship with
outcome. Relatively small sample sizes may overestimate
effect sizes or even produce conflicting results.
Conclusion Low power tests, generally achieved with
small sample sizes, may produce misleading conclusions,
especially when they are based only on p values and the
dichotomized criteria of rejecting/not-rejecting the null
hypothesis. We recommend reporting confidence intervals
and effect sizes in a more complete and contextualized data
analysis.
Keywords Traumatic brain injury  Outcome prediction 
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Introduction
Traumatic brain injury (TBI) is a major cause of worldwide
morbidity and mortality [1]. Identifying factors that might
indicate a poorer prognosis is important for proper man-
agement of TBI patients [2]. While some predictive factors
may be related to patient demographics (such as age, sex)
and initial factors related to primary injury—as Glasgow
Coma Scale (GCS)—other factors may be derived from
physiologic variables that can reflect secondary brain
injuries and, therefore, offer the possibility of informing
management protocols.
The use of physiological and demographic variables as
predictors of patient outcome has been largely discussed in
the literature [2–5]. In particular, high time-resolution
multimodal monitoring allows for an extended assessment
of secondary injury after TBI [6]. However, because of
difficulties in obtaining large datasets of high-resolution
physiological signals, some studies have relatively small
sample sizes. The failure to find a relationship between a
physiological variable (or a derived index) and outcome
where one truly exists (type II statistical error) could pre-
maturely end research on a promising ‘physio-marker’.
Conversely, finding a spurious relationship between a
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monitored variable or index when one does not exist (type I
statistical error) may take significant time to be rectified in
the scientific community, especially with the acknowl-
edged ‘positive results publication bias’.
The objective of this study is to highlight potential pit-
falls when only p values are used to interpret results from
relatively small datasets. More specifically, we explored
the role of sample size when physiological and demo-
graphic variables are associated with patient outcome using
univariate binary logistic regression models. In this con-
text, we also estimated the minimum sample sizes needed
to obtain reproducible results.
Methods
Data from head-injured patients having full record of
monitored variables of interest, connected to a bedside
computerized system (software: ICM [1992–2003], War-
saw University of Technology, Poland, and University of
Cambridge, UK, and later ICM+ [2003–2015] http://
www.neurosurg.cam.ac.uk/icmplus Cambridge Enterprise,
Cambridge, UK) with invasive monitoring of ABP and ICP
over a period longer than 12 h were included in this ret-
rospective analysis. ABP was invasively monitored
through a catheter in the radial artery; the pressure trans-
ducer was zeroed at heart level. ICP was continuously
monitored with Codman parenchymal probes (Johnson &
Johnson Medical, Raynham, MA, USA) via a cranial
access device (Technicam, Newton Abbott, UK). Probes
were positioned at a constant depth in the white matter,
pericontusional in focal injuries or in the nondominant
frontal lobe in diffuse injuries. Patients were managed
according to international TBI guidelines [7]. Patients were
sedated, intubated, and ventilated. Interventions were
aimed at keeping ICP < 20 mm Hg using a stepwise
approach of positioning, sedation, neuromuscular paralysis,
mild hyperventilation, ventriculostomy, osmotic agents,
and induced hypothermia [8]. Cerebral perfusion pressure
(CPP) was maintained >60 mm Hg using intravenous
fluids and vasopressors. Computerized indices did not form
a part of the management algorithm. The Glasgow Out-
come Scale (GOS) was assessed at 6 months by outpatient
assessment [9]. The digital recording of high-resolution
data for further anonymous use in academic publications
has been approved by the institutional ethics committee (29
REC 97/291) and local neurocritical care users’ committee.
Patients were divided between two groups, favorable
(FAV) and unfavorable (UNF), according to their GOS
score: 1—Death (D); 2—Persistent Vegetative State
(PVS); 3—Severe disability (SD); 4—Moderate Disability
(MD) and 5—Good Recovery (GR). The proportions of
each GOS score for each variable are presented in Table 1.
Three different dichotomizations were used in this
study: Dicho1 contains GOS 1 for UNF and GOS 2–5 for
FAV. Dicho 2 comprises GOS 1–2 for UNF and GOS 3–5
for FAV, and finally, Dicho 3 consist of GOS 1–3 and GOS
4–5 for UNF and FAV groups, respectively. The demo-
graphic variables used for outcome association are age
GCS. The physiological variables were averaged over the
entire NCCU stay. They are arterial blood pressure (ABP),
intracranial pressure (ICP), amplitude of ICP pulse (AMP),
magnitude of ICP slow waves (Slow), cerebral perfusion
pressure (CPP), pressure reactivity index (PRx), and
compensatory reserve index (RAP). There is substantial
literature about these indices; for a useful description see
[6].
Bootstrapping
One of the objectives of this study is to obtain the incidence
of statistically significant results when different sample
sizes are used. The straightforward approach would be to
consider all possible combinations of patients from the
dataset, for a given sample size, and obtain the statistics for
each case. However, this would be impracticable since
there are approximately 1048 possible combinations for a
sample size (N = 30 for example). A more appropriate
approach is to use a bootstrapping method to estimate the
probability distribution of the chosen statistic.
We examined samples of N = 20 up to N = 15,000.
Patients for each N were randomly chosen with reposition.
A univariate logistic regression was applied, and the odds
ratio (OR) of favorable versus unfavorable outcome was
obtained with its respective p value. This process was
repeated 10,000 times for each sample size and for each
variable. Thus, we can estimate the minimum sample size
required to obtain a statistically significant result in 90 %
of the drawings.
Results
Using ICP and dichotomization Dicho 1 as an example,
Fig. 1 presents the box plots for the odds ratio (OR) as well
as the p values for different sample sizes (N). For small
sample sizes, the variability of OR and p values is larger
and gets smaller with increasing N. The incidence of sig-
nificant results increases with sample size, reaching 90 %
at N = 140.
Considering only statistically significant results
(p < 0.05), Fig. 2 compares the OR and 95 % confidence
interval sizes obtained in 1000 random samples for two
different sizes, N = 30 and N = 200. For N = 30 (open
squares), the values of OR obtained are more dispersed
varying from 1.2 to 1.4 and the sizes for the 95 % CI are
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also larger from 0.2 to 0.6. On the other hand, for N = 200,
the values of OR varies between 1.05 and 1.15 and the
95 % CI size is around 0.1. The statistics variability for
small sample sizes is responsible for producing conflicting
results as pointed out by the arrow in Fig. 2. With the same
sample size (N = 30), the odds ratio may be statistically
significant below one (OR < 1) or above one (OR > 1).
The minimum sample size (Nmin) needed to obtain 90 %
incidence of significant results for each predictor variable
considered in this study is presented in Table 2. Minimum
sample sizes generally decrease for more restrictive con-
ditions for unfavorable outcome, i.e., Nmin are smaller for
Dicho 1 and 2. With the exception of RAP and both
demographic variables (age and GCS), the addition of SD
patients increases the effect sizes and therefore diminishes
Nmin. For CPP and AMP, the inclusion of SD patients in the
unfavorable group reduces considerably the associative
power of those variables, with estimated Nmin greater than
15,000.
Discussion
In the current analysis, PRx, ICP, and ICP slow waves
offered the strongest relationship with outcome. This result
highlights the importance of impaired pressure reactivity
Table 1 Number of patients for
each variable and the
proportions among different
GOS scores
Variable Outcome Total
D PVS SD MD GR
ABP 171 (22 %) 14 (2 %) 241 (31 %) 193 (25 %) 147 (20 %) 766
Age 172 (22 %) 15 (2 %) 246 (32 %) 191 (25 %) 149 (19 %) 773
AMP 165 (22 %) 15 (2 %) 244 (32 %) 193 (25 %) 149 (19 %) 766
CPP 171 (22 %) 14 (2 %) 242 (31 %) 193 (25 %) 149 (20 %) 769
GCS 125 (22 %) 8 (1 %) 162 (29 %) 140 (25 %) 122 (23 %) 557
ICP 172 (22 %) 15 (2 %) 244 (31 %) 194 (25 %) 151 (20 %) 776
PRx 156 (22 %) 14 (2 %) 231 (32 %) 180 (25 %) 136 (19 %) 717
RAP 170 (22 %) 15 (2 %) 245 (32 %) 194 (25 %) 149 (19 %) 773
Slow 167 (22 %) 15 (2 %) 244 (32 %) 193 (25 %) 149 (19 %) 768
D death, PVS persistent vegetative state, SD severe disability, MD moderate disability, GR good recovery,
ABP arterial blood pressure, AMP amplitude of intracranial pressure pulse, CPP cerebral perfusion pres-
sure, GCS glasgow coma score, ICP intracranial pressure, PRx pressure reactivity index, RAP
compensatory reserve index, Slow magnitude of intracranial pressure slow waves
Fig. 1 Considering ICP as the predictor variable in (a) box plot of the
odds ratio and respective p values, in (b) as a function of sample size
N obtained in 105 tests, in (c) the incidence of p values below the
significance level of 5 %. The larger the sample size, the better the
reproducibility of the result. Arrows indicate the minimum sample
size for ICP (Nmin = 100) in order to obtain reproducible results 90 %
of the time
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and intracranial hypertension as secondary injuries in TBI
[4].
The incidence of p values below the significance level,
obtained through bootstrapping, can be interpreted as an
estimate power of the test, i.e., its sensitivity. It is well
described in the literature that power increases with sample
size [10]. However, studies with small sample sizes
(N = 30–50) can be found quite frequently even in good
journals and therefore low statistical power is usually
employed [11]. Underpowered tests may provide a statis-
tically significant result that not only fails when it comes to
its reproducibility but also overestimates its clinical rele-
vance; both sensitivity and positive predictive value (PPV)
are low for underpowered tests [11].
For instance, in a study with N = 30 patients, the odds
ratio that increasing ICP will increase the odds for unfa-
vorable outcome will most likely not be statistically
significant; hence, one will not have enough evidence that
increased ICP is related to worse outcome. Note that this
does not imply that increased ICP is not related to worse
outcome; the absence of evidence is not the evidence of
absence. A non-significant result just means that there is
insufficient information to prove the proposition to be
either true or false; more data are needed to gather more
evidence against the null hypothesis. But we must keep in
mind that a large enough sample will eventually produce a
statistically significant result [11] and, consequently, it
should be interpreted in the light of its clinical relevance.
Also, a statistically significant result in this scenario will
most likely overestimate its effect size and consequently its
clinical relevance, the well-known ‘‘winner’s curse’’ [12].
In addition, the variability of OR and p values for small
sample sizes may produce misleading conclusions. The
conflicting result presented in Fig. 2, with significant result
for OR > 1 and OR < 1, illustrates the point that without
any additional information other than the dichotomized
criteria of rejecting/not-rejecting the null hypothesis, it is
difficult to come up with any meaningful conclusions and
there are no means to access the reproducibility of the
results.
Limitations
The current study considered the use of a univariate logistic
regression analysis for outcome association, and sample
size (N) considered in the analysis is evenly distributed
between groups. Although outcome prediction in TBI is
obviously a multivariate problem, for the current analysis
we wished simply to highlight the importance of consid-
ering a more complete description of the statistical results
rather than just p values.
The particular ‘optimal sample sizes’ (Nmin) obtained
are for illustrative purposes only, rather than a research
framework, because they were constructed using data from
only one research center and, therefore, may not be
applicable for other datasets. Furthermore, they deal with a
specific characteristic of the analysis, which is 90 %
power. There are other alternative criteria to select optimal
sample sizes, for instance the ‘‘planning for precision’’,
which calculates the sample size required for estimating the
effect size to reach a defined degree of precision [13].
Rather than just prescribing a minimum sample size
needed for publication of results, the current study high-
lights potential pitfalls when searching for physiologic
indices that predict outcome [14–18]. At least in the field of
TBI research, relationships between monitored variables
and outcome must be carefully interpreted when sample
sizes less than 100 are used. This result only reinforces the
Fig. 2 Considering only significant results (p < 0.05), odds ratio,
and 95 % confidence interval sizes for 1000 results with sample size
N = 30 and N = 200. For small sample sizes (open squares), the
obtained effect size (OR) is overestimated and the so-called winner’s
curse and the confidence intervals are larger. Also, the arrow points to
possible conflicting results (OR < 1) that may occur when sample
sizes are small
Table 2 Estimated minimum sample sizes (Nmin) required for each
physiological variable for 90 % incidence of p values below 0.05
Dicho ABP Age AMP CPP GCS ICP PRx RAP Slow
1 1300 370 850 550 800 140 140 560 160
2 2300 380 800 450 850 155 150 660 170
3 1200 280 – – 380 370 190 370 380
Tests were performed considering different dichotomizations between
favorable and unfavorable outcomes
Dicho 1 compares GOS 1 versus GOS 2–5, Dicho 2 GOS 1–2 versus
GOS 3–5, Dicho 3 GOS 1–3 versus GOS 4 and 5, ABP arterial blood
pressure, AMP amplitude of intracranial pressure pulse, CPP cerebral
perfusion pressure, GCS glasgow coma score, ICP intracranial pres-
sure, PRx pressure reactivity index, RAP compensatory reserve index,
Slow magnitude of intracranial pressure slow waves
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importance of multicenter studies when it comes to clinical
neuroscience.
Conclusion
Consistent with other opinion, we recommend a more
complete and contextualized description of results. Sample
size, effect size, power, and confidence intervals should all
be considered in addition to p values when interpreting
results from statistical inferences. Relying only on p values
as the final word can produce misleading conclusions,
especially when combined with the dichotomized criteria
of rejecting/not-rejecting the null hypothesis.
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